182 related articles for article (PubMed ID: 32529817)
1. Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer.
Lilge L; Wu J; Xu Y; Manalac A; Molenhuis D; Schwiegelshohn F; Vesselov L; Embree W; Nesbit M; Betz V; Mandel A; Jewett MAS; Kulkarni GS
J Biomed Opt; 2020 Jun; 25(6):1-13. PubMed ID: 32529817
[TBL] [Abstract][Full Text] [Related]
2. PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).
Ong YH; Kim MM; Finlay JC; Dimofte A; Singhal S; Glatstein E; Cengel KA; Zhu TC
Phys Med Biol; 2017 Dec; 63(1):015031. PubMed ID: 29106380
[TBL] [Abstract][Full Text] [Related]
3. Integrating sphere effect in whole-bladder wall photodynamic therapy: III. Fluence multiplication, optical penetration and light distribution with an eccentric source for human bladder optical properties.
van Staveren HJ; Keijzer M; Keesmaat T; Jansen H; Kirkel WJ; Beek JF; Star WM
Phys Med Biol; 1996 Apr; 41(4):579-90. PubMed ID: 8730658
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model.
Berndt-Paetz M; Schulze P; Stenglein PC; Weimann A; Wang Q; Horn LC; Riyad YM; Griebel J; Hermann R; Glasow A; Stolzenburg JU; Neuhaus J
Mol Cancer Ther; 2019 Apr; 18(4):743-750. PubMed ID: 30824608
[TBL] [Abstract][Full Text] [Related]
5. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB
BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396
[TBL] [Abstract][Full Text] [Related]
6. Tumor reactive ringlet oxygen approach for Monte Carlo modeling of photodynamic therapy dosimetry.
Lopez N; Mulet R; Rodríguez R
J Photochem Photobiol B; 2016 Jul; 160():383-91. PubMed ID: 27197059
[TBL] [Abstract][Full Text] [Related]
7. An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer.
Yavari N; Andersson-Engels S; Segersten U; Malmstrom PU
Can J Urol; 2011 Aug; 18(4):5778-86. PubMed ID: 21854709
[TBL] [Abstract][Full Text] [Related]
8. Hexyl-aminolevulinate-mediated photodynamic therapy: how to spare normal urothelium. An in vitro approach.
Vaucher L; Jichlinski P; Lange N; Ritter-Schenk C; van den Bergh H; Kucera P
Lasers Surg Med; 2007 Jan; 39(1):67-75. PubMed ID: 17096415
[TBL] [Abstract][Full Text] [Related]
9. Bladder PDT with intravesical clear and light scattering media: effect of an eccentric isotropic light source on the light distribution.
van Staveren HJ; Bertrams RH; Star WM
Lasers Surg Med; 1997; 20(3):248-53. PubMed ID: 9138253
[TBL] [Abstract][Full Text] [Related]
10. Integrating sphere effect in whole bladder wall photodynamic therapy: I. 532 nm versus 630 nm optical irradiation.
van Staveren HJ; Beek JF; Ramaekers JW; Keijzer M; Star WM
Phys Med Biol; 1994 Jun; 39(6):947-59. PubMed ID: 15551572
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of deep tissue abscess cavities: Retrospective image-based feasibility study using Monte Carlo simulation.
Baran TM; Choi HW; Flakus MJ; Sharma AK
Med Phys; 2019 Jul; 46(7):3259-3267. PubMed ID: 31056771
[TBL] [Abstract][Full Text] [Related]
12. Modeling PpIX effective light fluence at depths into the skin for PDT dose comparison.
LaRochelle EPM; Marra K; LeBlanc RE; Chapman MS; Maytin EV; Pogue BW
Photodiagnosis Photodyn Ther; 2019 Mar; 25():425-435. PubMed ID: 30685548
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species explicit dosimetry to predict tumor growth for benzoporphyrin derivative-mediated vascular photodynamic therapy.
Sheng T; Ong YH; Guo W; Zhu T
J Biomed Opt; 2020 Jan; 25(6):1-13. PubMed ID: 31912689
[TBL] [Abstract][Full Text] [Related]
14. TLD1433-Mediated Photodynamic Therapy with an Optical Surface Applicator in the Treatment of Lung Cancer Cells In Vitro.
Chamberlain S; Cole HD; Roque J; Bellnier D; McFarland SA; Shafirstein G
Pharmaceuticals (Basel); 2020 Jun; 13(7):. PubMed ID: 32605213
[TBL] [Abstract][Full Text] [Related]
15. Advances in Management of Bladder Cancer-The Role of Photodynamic Therapy.
Kubrak T; Karakuła M; Czop M; Kawczyk-Krupka A; Aebisher D
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163996
[TBL] [Abstract][Full Text] [Related]
16. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.
Lilge L; Molpus K; Hasan T; Wilson BC
Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583
[TBL] [Abstract][Full Text] [Related]
17. Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumours.
Shackley DC; Whitehurst C; Moore JV; George NJ; Betts CD; Clarke NW
BJU Int; 2000 Oct; 86(6):638-43. PubMed ID: 11069369
[TBL] [Abstract][Full Text] [Related]
18. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
[TBL] [Abstract][Full Text] [Related]
19. In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer.
Dimofte A; Zhu TC; Hahn SM; Lustig RA
Lasers Surg Med; 2002; 31(5):305-12. PubMed ID: 12430147
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study.
Berger AP; Steiner H; Stenzl A; Akkad T; Bartsch G; Holtl L
Urology; 2003 Feb; 61(2):338-41. PubMed ID: 12597942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
